Separation Science: Driving Pharmaceutical Development and Manufacture
The Chromatographic Society and the Royal Society of Chemistry Analytical Division North East Region has organized a meeting to be held on 22 November 2018 in the Stadium of Light, Sunderland, UK.
Photo Credit: The Chromatographic Society
The Chromatographic Society and the Royal Society of Chemistry Analytical Division North East Region has organized a meeting to be held on 22 November 2018 in the Stadium of Light, Sunderland, UK.
The organizers are planning to make the conference a little different than usual. The meeting will not be introducing new chromatographic innovations to pharmaceutical researchers. Instead, the conference will reflect on the enduring strength of pharmaceutical development and manufacture in the UK. The unmet analytical challenges facing these areas of the industry will be explored and emerging technologies reviewed to assess those that potentially offer the best solutions for the immediate future. Ahead of the meeting analytical scientists supporting pharmaceutical development and manufacture will be invited to comment on the most important unmet analytical needs they are facing, with a view to speakers and vendors responding at the meeting. For more information, please visit: http://chromsoc.com/event/seperation-science-driving-pharmaceutical-development-and-manufacture
For initial enquiries please contact:
Scientific programme: john.lough@sunderland.ac.uk
Exhibition opportunities: heather.linnell@agilent.com
Local arrangements: roger.reeve@sunderland.ac.uk
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
